Clinical study of trastuzumab deruxtecan combined with stereotactic radiotherapy for the treatment of HER2-positive and HER2-low breast cancer patients with brain metastases

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 14f81ecacd9a5c7b7660835ee0b5ebe6d95bd5ce
First added on: May 09, 2026